Literature DB >> 7706013

The ranking properties of healthy-years equivalents and quality-adjusted life-years under certainty and uncertainty.

M Johannesson1.   

Abstract

This paper investigates the theoretical properties of healthy-years equivalents (HYEs) and quality-adjusted life-years (QALYs). A distinction is made between ex ante HYEs (EA-HYEs) and expected HYEs (EXP-HYEs) and between risk-neutral quality-adjusted life-years (RN-QALYs) and risk-adjusted quality adjusted life-years (RA-QALYs). In the case of certainty, HYEs always rank health profiles according to individual preferences, whereas QALYs only rank health profiles according to individual preferences if constant proportional trade-off holds for all health states and if additive independence of quality in different periods holds. In the case of uncertainty, EA-HYEs always rank risky health profiles the same way as expected utility. The assumptions needed for the other measures to rank risky health profiles the same way as expected utility are: risk neutrality with respect to healthy time for EXP-HYEs; risk neutrality with respect to time in all health states and additive independence of quality in different periods for RN-HYEs; and constant proportional risk posture with respect to time in all health states and additive independence of quality in different periods for RA-QALYs.

Mesh:

Year:  1995        PMID: 7706013     DOI: 10.1017/s0266462300005249

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  4 in total

1.  Holistic preferences for 1-year health profiles describing fluctuations in health: the case of chronic obstructive pulmonary disease.

Authors:  Maureen P M H Rutten-van Mölken; Martine Hoogendoorn; Leida M Lamers
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

2.  Alternatives to the QALY measure for economic evaluations.

Authors:  A Gafni
Journal:  Support Care Cancer       Date:  1997-03       Impact factor: 3.603

3.  Capturing disutility from waiting time.

Authors:  Afschin Gandjour
Journal:  Pharmacoeconomics       Date:  2014-04       Impact factor: 4.981

4.  Validation of the underlying assumptions of the quality-adjusted life-years outcome: results from the ECHOUTCOME European project.

Authors:  Ariel Beresniak; Antonieta Medina-Lara; Jean Paul Auray; Alain De Wever; Jean-Claude Praet; Rosanna Tarricone; Aleksandra Torbica; Danielle Dupont; Michel Lamure; Gerard Duru
Journal:  Pharmacoeconomics       Date:  2015-01       Impact factor: 4.981

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.